Discover how therapeutic peptides act as biological messengers to treat disease, improve metabolism, and enhance immune ...
Matchpoint Therapeutics has publicly launched with $70 million in series A financing and an earlier $30 million in seed money to develop covalent drugs for immune diseases. Its founders include ...
Although small molecules can be excellent at finding and binding deep pockets on proteins of interest, many therapeutic targets with smooth surfaces remain hard to get a good handle on. Partly as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results